Form 4: Modular Medical Director Carmen Volkart Reports Acquisition of Shares and Options

Sentiment:

SEC Form 4 Filing


Director Carmen Volkart acquired 625 shares of common stock and options to purchase 7,500 shares of Modular Medical, Inc. on September 30, 2024.

Summary

  • On September 30, 2024, Carmen Volkart, a director of Modular Medical, Inc., acquired 625 shares of common stock.
  • These shares were issued to Volkart in accordance with the company's Outside Director Compensation Plan.
  • Volkart also acquired options to purchase 7,500 shares of common stock at an exercise price of $2.28 per share.
  • The options were granted under the Issuer's Outside Director Compensation Plan and were fully vested and exercisable on the grant date, expiring on September 30, 2034.
  • Following these transactions, Volkart beneficially owns 10,835 shares of common stock and options for 7,500 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock and option acquisitions by a director, which doesn't inherently indicate positive or negative sentiment.

Positives

  • A director's acquisition of shares and options may signal confidence in the company's future prospects.
  • The options granted to the director are fully vested immediately, aligning their interests with the company's short-term performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to insider transactions, common in the context of publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders, which is important for investor confidence and regulatory compliance.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.
  • The acquisition of shares and options by a director could be perceived positively by stakeholders, indicating confidence in the company's prospects.

Key Dates

DateDescription
09/30/2024Date of the transaction: acquisition of shares and options.
09/30/2024Date the options were granted and became exercisable.
09/30/2034Expiration date of the options.
10/02/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.